Today's News | Note: News feeds may no longer be available for the articles on this page.

Hospira stops shipping generic drug pending case 12:01 PM 8/17/2009
Forbes
Hospira Inc stopped selling chemotherapy drug oxaliplatin injection, the generic of Eloxatin days after it got regulatory approval. Sanofi-Aventis went to court to block shipments. ...

AEterna plunges on prostate drug trial failure 12:00 PM 8/17/2009
Forbes
AEterna Zentaris Inc said its prostate drug cetrorelix pamoate failed in a late-stage clinical trial. ...

US ruling could affect Canadian drugmakers 10:01 AM 8/17/2009
Reuters
A US court ruling that paves the way for a generic painkiller could hurt Biovail Corp and Labopharm. ...

Protalix's Gaucher drug treatment protocol gets FDA nod 8:08 AM 8/17/2009
Reuters
Protalix BioTherapeutics Inc said the US FDA approved the treatment protocol for the company's experimental prGCD drug for Gaucher disease. ...

Novartis Copy of Bayer's Betaseron MS Drug Wins US Approval 5:10 AM 8/17/2009
Bloomberg
Novartis won US FDA approval to sell its Extavia multiple sclerosis treatment which is a form of interferon beta-1b similar to Bayer AG’s Betaseron. ...

Drug-resistant swine flu cases discovered in patients in Seattle 9:49 AM 8/15/2009
Boston Herald
The country’s first cases of drug-resistant swine flu were discovered in two leukemia patients who had weakened immune systems from chemotherapy and stem-cell transplants. ...

GlaxoSmithKline starts clinical trials on H1N1 swine flu vaccine 11:49 AM 8/14/2009
Bizjournals.com
GlaxoSmithKline intends to test the vaccine on over 9,000 people in 16 separate clinical trials across Europe, the US, and Canada. ...

Analysts reaffirm high hopes for Amgen bone drug 9:49 AM 8/14/2009
Forbes
A US FDA advisory panel voted unanimously in favor of Amgen's denosumab as a treatment for postmenopausal osteoporosis. ...

Roche transplant drug gets anemia warning 7:33 AM 8/14/2009
Reuters
Roche Holding's transplant drug CellCept will carry a new warning about a type of anemia seen in some patients to include information about cases of pure red cell aplasia (PRCA). ...

FDA OKs Schering-Plough Drug for Schizophrenia, Bipolar 5:49 AM 8/14/2009
Wall Street Journal
The US FDA gave final approval to Schering-Plough's Saphris (asenapine) as a treatment for both schizophrenia and bipolar disorder in adults. ...

Antigenics launches trial for glioma vaccine 10:49 AM 8/13/2009
Bizjournals.com
Antigenics Inc is enrolling patients in a Phase 2 clinical trial for a potential vaccination to treat a specific form of brain and spinal cancer. ...

BioSante says lead drug safe in late-stage study 7:47 AM 8/13/2009
Reuters
BioSante Pharmaceuticals' lead candidate LibiGel to treat female sexual dysfunction was safe in the late-stage cardiovascular and breast cancer safety study. ...

Genzyme warned patients of Gaucher-drug rationing 10:29 AM 8/12/2009
Bizjournals.com
Genzyme will only ship the Gaucher disease treatment Cerezyme to children and the sickest adults. Disruption to the supply was caused by manufacturing plant contamination. ...

US rules aim to help dying patients access drugs 8:28 AM 8/12/2009
Reuters
The US FDA tries to achieve a balance between good science and the fact that critically ill patients urgently want access. ...

Avanir drug meets main study goal; stock soars 9:29 AM 8/11/2009
Reuters
Avanir Pharmaceuticals Inc said a reformulated version of its Zenvia drug reduced emotional outbursts tied to a neurological disorder. ...

<- Day Earlier | Today's News